T. Rowe Price Associates
RTO icon

T. Rowe Price Associates’s Rentokil RTO Stock Holding History

T. Rowe Price Associates’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188,901
Closed -$5.6M – 3022
2024
Q2 		$5.6M Sell
188,901
-745,113
-80% -$20.7M ﹤0.01% 1195
2024
Q1 		$28.2M Sell
934,014
-213,339
-19% -$5.92M ﹤0.01% 883
2023
Q4 		$32.8M Sell
1,147,353
-112,804
-9% -$3.31M ﹤0.01% 820
2023
Q3 		$46.7M Sell
1,260,157
-183,060
-13% -$6.99M 0.01% 705
2023
Q2 		$56.3M Sell
1,443,217
-1,821
-0.1% -$71.4K 0.01% 671
2023
Q1 		$52.8M Sell
1,445,038
-219,706
-13% -$6.93M 0.01% 673
2022
Q4 		$51.3M Buy
+1,664,744
New +$51.7M 0.01% 652

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
HP
Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates's RTO Position: Q3 2024 in Review

T. Rowe Price Associates sold out of Rentokil (RTO) in Q3 2024, closing a stake of 188,901 shares — an estimated $5.6M sold.

T. Rowe Price Associates first reported a position in RTO in Q4 2022 and held it in 7 quarters. The position peaked at $56.3M in Q2 2023. 220 funds tracked by Wall St. Rank hold RTO as of Q3 2024.

  • T. Rowe Price Associates reported no remaining Rentokil position as of Q3 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 188,901 Rentokil shares in Q3 2024, an estimated $5.6M.
  • T. Rowe Price Associates first reported a position in Rentokil in Q4 2022 and held it in 7 quarters.
  • T. Rowe Price Associates's Rentokil position peaked at $56.3M in Q2 2023.
  • 220 funds tracked by Wall St. Rank held Rentokil as of Q3 2024.

Based on T. Rowe Price Associates's 13F filing for Q3 2024, filed 14 Nov 2024.